Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-alpha inhibitors in selected patients in developing countries?

J Rheumatol. 2010 Mar;37(3):672-3; author reply 673. doi: 10.3899/jrheum.090672.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • Antitubercular Agents / therapeutic use*
  • Developing Countries
  • Female
  • Humans
  • India
  • Latent Tuberculosis / chemically induced
  • Latent Tuberculosis / diagnosis*
  • Latent Tuberculosis / prevention & control*
  • Male
  • Mexico
  • Middle Aged
  • Rheumatic Diseases / drug therapy*
  • Sensitivity and Specificity
  • Tuberculin Test*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Antitubercular Agents
  • Tumor Necrosis Factor-alpha